UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000050240
Receipt number R000052021
Scientific Title Evaluation of dementia-preventing effect of multitasking exercise by beta amyloid : 18-month randomized trial
Date of disclosure of the study information 2023/05/01
Last modified on 2023/02/05 13:28:30

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Evaluation of dementia-preventing effect of multitasking exercise by beta amyloid : 18-month randomized trial

Acronym

Evaluation of dementia prevention effect of multitasking exercise by beta amyloid

Scientific Title

Evaluation of dementia-preventing effect of multitasking exercise by beta amyloid : 18-month randomized trial

Scientific Title:Acronym

Evaluation of dementia prevention effect of multitasking exercise by beta amyloid

Region

Japan


Condition

Condition

Healthy subjects

Classification by specialty

Not applicable Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

In order to elucidate the dementia-preventing effect of SSE biochemically, Beta amyloid will be measured as the primary endpoints by Muldi-TOFMS. And cognitive function will be measured as a secondary endpoint in RCT (3 groups, intervention period 18 months).

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Explanatory

Developmental phase

Not applicable


Assessment

Primary outcomes

Composite biomarker (Beta amyloid 1-40, beta amyloid 1-42, beta amyloid protein precursor 669-711)

Key secondary outcomes

cognitive function
Physical function
Physical activity
Mental health


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

No treatment

Stratification

YES

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

No need to know


Intervention

No. of arms

3

Purpose of intervention

Treatment

Type of intervention

Behavior,custom

Interventions/Control_1

Square-stepping exercise

Interventions/Control_2

Walking

Interventions/Control_3

Control

Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

65 years-old <=

Age-upper limit

85 years-old >=

Gender

Male and Female

Key inclusion criteria

1) A person who participated in the blood sampling test conducted by Kasama City in 2019
2) A person who is not prohibited from exercising by their doctor
3) A person who can go to the place where the experiment is conducted on their own

Key exclusion criteria

1) A person with dementia
2) A person with paralysis
3) A person who has an allergic reaction to the ingredients of the test food
4) A person who is currently participating in other clinical studies or who have participated within 3 months
5) A person who is judged by the principal investigator to be inappropriate as the subjects of this study

Target sample size

224


Research contact person

Name of lead principal investigator

1st name Okura
Middle name
Last name Tomohiro

Organization

University of Tsukuba

Division name

Faculty of Health and sport science

Zip code

305-8574

Address

1-1-1 Tennodai, Tsukuba, Ibaraki, Japan

TEL

+81-29-853-2733

Email

okura.tomohiro.gp@u.tsukuba.ac.jp


Public contact

Name of contact person

1st name YOON
Middle name
Last name Jieun

Organization

University of Tsukuba

Division name

R&D Center for Tailor-Made QOL

Zip code

305-8550

Address

1-2, kasuga, Tsukuba, Ibaraki, Japan

TEL

+81-029-839-1593

Homepage URL


Email

yoon.jieunfu@u.tsukuba.ac.jp


Sponsor or person

Institute

University of Tsukuba

Institute

Department

Personal name



Funding Source

Organization

Ministry of Education, Culture, Sports, Science and Technology (MEXT)

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

University of Tsukuba, Faculty of Health and sport science, Research Ethics Committee

Address

1-1-1 Tennodai, Tsukuba, Ibaraki, Japan

Tel

+81-029-853-2571

Email

tg-kenkyurinri@un.tsukuba.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2023 Year 05 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2020 Year 10 Month 01 Day

Date of IRB

2021 Year 11 Month 05 Day

Anticipated trial start date

2021 Year 12 Month 01 Day

Last follow-up date

2022 Year 12 Month 31 Day

Date of closure to data entry

2023 Year 03 Month 31 Day

Date trial data considered complete

2023 Year 04 Month 30 Day

Date analysis concluded

2023 Year 05 Month 30 Day


Other

Other related information



Management information

Registered date

2023 Year 02 Month 05 Day

Last modified on

2023 Year 02 Month 05 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000052021